Skip to main content
MedPathMedPath Home
Clinical Trials/JPRN-UMIN000053532
JPRN-UMIN000053532
Recruiting
未知

A multicenter observational study on the efficacy and safety of systemic therapy for hepatocellular carcinoma - A multicenter observational study on the efficacy and safety of systemic therapy for hepatocellular carcinoma

Kyoto University0 sites750 target enrollmentFebruary 3, 2024
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Kyoto University
Enrollment
750
Status
Recruiting
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 3, 2024
End Date
March 31, 2028
Last Updated
last year
Study Type
Observational
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • •Patient without adequate baseline information due to reasons such as an initiation of treatment at another institution Patients without adequate follow\-up period for reasons such as transferring to another hospital before radiological assessment of treatment response Patients considered inappropriate as subjects for this study by the principal investigator or researchers involved in the study

Outcomes

Primary Outcomes

Not specified

Similar Trials

Recruiting
Phase 4
Multicenter observational study of the efficancy of sitagliptin in patients at high risk of cardiovascular diseasetype 2 diabetes mellitus
JPRN-UMIN000005663Division of Cardiology,Department of Internal Medicine,Kinki University School of Medicine500
Recruiting
Not Applicable
A Multicenter Prospective Study on the Efficacy of Small Intestinal Capsule Endoscopy in Hemodialysis Patients
JPRN-UMIN000041904Keio university school of medicine500
Completed
Not Applicable
A multicenter retrospective study of the efficacy of statins in unresectable or recurrent advanced biliary tract cancer patients.
JPRN-UMIN000046659Keio University Hospital1,500
Recruiting
Phase 2
A Clinical Trial to study the effects of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis
CTRI/2012/11/003145ovaBay Pharmaceutical Inc440
Completed
Not Applicable
A Clinical Trial to study the effects of NVC-422 Ophthalmic Solution for the Treatment of Adenoviral ConjunctivitisAdenoviral Conjunctivitis
SLCTR/2013/026ovaBay Pharmaceutical, Inc